Radiotherapy Market, By Product Type (External Beam Radiation, Internal Beam Radiation, and Systemic Radiation), By Therapy Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy, and Systemic Radiation Therapy), By Application (Prostate Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, and Others), By End User (Hospitals, Oncology Clinics and Ambulatory Radiotherapy Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : May 2024

Code : CMI1320

Pages :205

Formats :

Excel and PDF

Industry : Medical Devices

Radiotherapy Market Size and Trends

The global radiotherapy market is estimated to be valued at USD 7.97 Bn in 2024 and is expected to reach USD 12.86 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7.1% from 2024 to 2031.

Radiotherapy Market Key Factors

To learn more about this report, request sample copy

The increasing prevalence of cancer around the world is the key factor driving the demand for radiotherapy. As per World Health Organization, cancer accounted for nearly 10 million deaths in 2020 and is one of the leading causes of mortality worldwide. Additionally, rising adoption of advanced treatment techniques, such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT), is also boosting the growth of the radiotherapy market. Furthermore, growing awareness about the therapeutic advantages of radiotherapy compared to other cancer treatment options is augmenting the market expansion.

Market Driver – Increasing Prevalence of Cancer

Rising prevalence of oncology diseases, such as prostate cancer, lung cancer, and breast cancer, globally is increasing the demand for timely management to reduce mortality associated with such conditions. This, in turn, is a major factor augmenting the growth of the radiotherapy market. For instance, according to data provided by Breastcancer.org, in March 2022, an estimated 287,850 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 51,400 new cases of non-invasive (in situ) breast cancer in 2022.

/p>Higher Efficacy of Radiotherapy Equipment with Enhanced Clinical Outcomes

The high-energy radiation used during radiotherapy permanently damages the DNA of cancer cells, causing them to die. According to the data provided by Mayo Foundation for Medical Education and Research (MFMER), in July 2020, almost half of all people with cancer have radiotherapy as part of their treatment plan. Moreover, according to the data published by NHS inform, in November 2021, four out of every 10 cancer cures include radiotherapy as part of the treatment plan.